AR-v7 protein expression is regulated by protein kinase and phosphatase

Yinan Li1, Ning Xie1, Martin E Gleave1

  • 1Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.

Oncotarget
|September 18, 2015
PubMed

Insights

New findings reveal how protein phosphatase-1 (PP-1) and Akt kinase control androgen receptor variant 7 (AR-v7) expression. This discovery is crucial for understanding castration-resistant prostate cancer (CRPC) progression despite anti-androgen therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Castration-resistant prostate cancer (CRPC) progression is linked to sustained androgen receptor (AR) and its splice variant AR-v7 expression.
  • Next-generation anti-androgens like enzalutamide inhibit AR activity, but AR-v7 remains active, driving CRPC.
  • The molecular mechanisms regulating AR-v7 protein expression are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms controlling AR-v7 protein expression in prostate cancer cells.
  • To investigate the roles of protein phosphatase-1 (PP-1) and Akt kinase in AR-v7 regulation.
  • To understand how these pathways influence AR-v7 activity during anti-androgen therapy.

Main Methods:

  • Utilized multiple prostate cancer cell models.
  • Investigated the activation of protein phosphatase-1 (PP-1) and Akt kinase.
  • Assessed AR phosphorylation status and Mdm2 ubiquitin ligase activation.
  • Examined AR-v7 ubiquitination and protein degradation.

Main Results:

  • Enzalutamide treatment induced differential activation of PP-1 and Akt kinase based on cellular context.
  • The balance between PP-1 and Akt activation determined AR phosphorylation.
  • Activated Mdm2 ligase recognized phosphorylated serine 213 on AR-v7, leading to its ubiquitination and degradation.

Conclusions:

  • PP-1 and Akt kinase play critical roles in regulating AR-v7 protein expression.
  • The PP-1/Akt balance dictates AR-v7 stability and activity.
  • Targeting PP-1 and Akt pathways could offer new therapeutic strategies for CRPC by controlling AR-v7.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K